Status: current, Defined. Date: 31-Jul 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4830671000168113 | Xeljanz XR (tofacitinib 11 mg) modified release tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4830681000168111 | Xeljanz XR 11 mg modified release tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Xeljanz XR 11 mg modified release tablet | Is a | Xeljanz XR | true | Inferred relationship | Some | ||
| Xeljanz XR 11 mg modified release tablet | Is a | tofacitinib 11 mg modified release tablet | true | Inferred relationship | Some | ||
| Xeljanz XR 11 mg modified release tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Xeljanz XR 11 mg modified release tablet | has manufactured dose form | modified release tablet | true | Inferred relationship | Some | ||
| Xeljanz XR 11 mg modified release tablet | has Australian BoSS | tofacitinib | true | Inferred relationship | Some | 1593987854 | |
| Xeljanz XR 11 mg modified release tablet | has intended active ingredient | tofacitinib | true | Inferred relationship | Some | 1593987854 | |
| Xeljanz XR 11 mg modified release tablet | has unit of use | tablet | true | Inferred relationship | Some | 1960238656 |
Reference Sets
Black Triangle Scheme reference set
Trade product unit of use reference set
FHIR